Funding

The Human Immunodeficiency Virus Laboratory has received targeted funding to support Dr. Badley's research.

Grants

Investigator & Role Grant Title Funding Source Duration
Andrew D. Badley, M.D., principal investigator Prime shock and kill for HIV erradication (R01AI110173) National Institute of Allergy and Infectious Diseases 02/15/14 - 04/30/24
Andrew D. Badley, M.D., principal investigator Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence (R01AI120698) National Institute of Allergy and Infectious Diseases 06/15/15 - 05/31/20
Andrew D. Badley, M.D., principal investigator Ixazomib to reduce HIV reservoir size amfAR-The Foundation for AIDS Research 02/06/17 - 01/06/19
Andrew D. Badley, M.D., principal investigator Enhancing control of HIV by inhibiting TRAILshort (R56AI102959) National Institute of Allergy and Infectious Diseases 02/06/13 - 01/06/15